BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Steele M, Voutsadakis IA. Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma. World J Gastrointest Oncol 2017; 9(1): 42-49 [PMID: 28144399 DOI: 10.4251/wjgo.v9.i1.42]
URL: https://www.wjgnet.com/1948-5204/full/v9/i1/42.htm
Number Citing Articles
1
Jaesik Kim, Kyung-Ah Sohn, Jung-Hak Kwak, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Hyun-Cheol Kang, Eui Kyu Chie, Sang-Hyuk Jung, Dokyoon Kim, Ji Won Park. A Novel Scoring System for Response of Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Using Early-Treatment Blood Features Derived From Machine LearningFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.790894
2
Debashish Ghose, Suryakanta Swain, Chinam Niranjan Patra, Bikash Ranjan Jena, Muddana Eswara Bhanoji Rao. Advancement and Applications of Platelet-inspired Nanoparticles: A Paradigm for Cancer TargetingCurrent Pharmaceutical Biotechnology 2023; 24(2): 213 doi: 10.2174/1389201023666220329111920
3
Claudio Belluco, Marco Forlin, Paolo Delrio, Daniela Rega, Maurizio Degiuli, Silvia Sofia, Matteo Olivieri, Salvatore Pucciarelli, Matteo Zuin, Giovanni De Manzoni, Alberto Di Leo, Stefano Scabini, Luigi Zorcolo, Angelo Restivo. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patientsBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5022-1
4
Chuan Li, Wei Peng, Xiao-Yun Zhang, Tian-Fu Wen, Li-Ping Chen. The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resectionMedicine 2019; 98(45): e17920 doi: 10.1097/MD.0000000000017920
5
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Cancer and Metastasis Reviews 2017; 36(2): 305 doi: 10.1007/s10555-017-9683-z
6
Joey Mercier, Ioannis A. Voutsadakis. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal CancerJournal of Gastrointestinal Cancer 2019; 50(3): 493 doi: 10.1007/s12029-018-0108-1
7
T�nia Gago, Paulo Caldeira, Catarina Cunha, Pedro Campelo, Horácio Guerreiro. Can we optimize the CEA as a response marker in rectal cancer?Revista Española de Enfermedades Digestivas 2020;  doi: 10.17235/reed.2020.7321/2020
8
Ioannis A. Voutsadakis. A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World SeriesCurrent Oncology 2023; 30(6): 5227 doi: 10.3390/curroncol30060397
9
Ioannis A. Voutsadakis. Presentation, Molecular Characteristics, Treatment, and Outcomes of Colorectal Cancer in Patients Older than 80 Years OldMedicina 2023; 59(9): 1574 doi: 10.3390/medicina59091574
10
AnnaLee Policicchio, Joey Mercier, Antonia Digklia, Ioannis A. Voutsadakis. Platelet and Neutrophil Counts as Predictive Markers of Neoadjuvant Therapy Efficacy in Rectal CancerJournal of Gastrointestinal Cancer 2019; 50(4): 894 doi: 10.1007/s12029-018-0173-5
11
Michael Lam, Jason Roszik, Preeti Kanikarla-Marie, Jennifer S. Davis, Jeffrey Morris, Scott Kopetz, David G. Menter. The potential role of platelets in the consensus molecular subtypes of colorectal cancerCancer and Metastasis Reviews 2017; 36(2): 273 doi: 10.1007/s10555-017-9678-9